Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort-Reference-Cited by-同舟云学术

Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort

Published:2021-11 Issue:11 Volume:32 Page:1410-1424
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Schrodi S.,Braun M.,Andrulat A.,Harbeck N.,Mahner S.,Kiechle M.,Klein E.,Schnelzer A.,Schindlbeck C.,Bauerfeind I.,Schubert-Fritschle G.,Nekljudova V.,Mayr D.,Weichert W.,Denkert C.,Loibl S.,Engel J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference31 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

2. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version);Hammond;Arch Pathol Lab Med,2010

3. Strategies for subtypes – dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011;Goldhirsch;Ann Oncol,2011

4. Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient;Goldhirsch;Breast,2013

5. Tailoring therapies – improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015;Coates;Ann Oncol,2015

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer;Cancer Treatment Reviews;2024-07

2. Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study;The Lancet Regional Health - Europe;2024-05

3. Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response;Exploration of Targeted Anti-tumor Therapy;2024-02-28

4. Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade;Cancers;2024-02-19

5. Prognostic factors for hormone receptor-positive breast cancer with liver metastasis and establishment of novel nomograms for prediction: a SEER-based study;Translational Cancer Research;2023-12